Enhanced Dialectical Behavior Therapy for Adolescents

November 20, 2025 updated by: Megan Plakos Szabo, Compass Behavioral Health

Enhanced Dialectical Behavior Therapy for Adolescents: Impacts of Individualized Skills Coaching on Constructs of Suicidality

Suicide is a leading cause of death and significant concerns for adolescents and young adults. Dialectical Behavior Therapy for Adolescents (DBT-A) is an evidence-based intervention that effectively reduces life-threatening behaviors. Limited research examines the impact of adding individualized skills coaching sessions (ISCS) to the DBT-A model, a novel intervention referred to in this paper as "Enhanced DBT-A". This study evaluates the effectiveness of Enhanced DBT-A in reducing suicidality over 1 year of treatment in an outpatient and intensive outpatient setting.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

47

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Tustin, California, United States, 92780
        • Compass Behavioral Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • appropriateness for Stage 1 DBT, completion of all assessments within the designated timeframe, a non-zero score on the Columbia-Suicide Severity Rating Scale (C-SSRS) at intake, and participation in at least one ISCS between intake and 1 year from the first individual therapy session.

Exclusion Criteria:

  • presenting with active psychosis, a primary diagnosis of substance use, who did not consent to data collection, or who had a zero score on the C-SSRS at intake

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Enhanced DBT-A Group
Participants engaged in Enhanced DBT-A services, including individual therapy, group skills training, phone coaching, and ISCS. Participants completed assessment batteries at intake, 6 months, and 1 year, and the outcome measures assessed participants' severity and intensity of suicidal ideation (SI), reasons for living, and depressive symptoms.
Participants engaged in Enhanced DBT-A services, including individual therapy, group skills training, phone coaching, and ISCS. Participants completed assessment batteries at intake, 6 months, and 1 year, and the outcome measures assessed participants' severity and intensity of suicidal ideation (SI), reasons for living, and depressive symptoms.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reasons for Living Inventory for Adolescents (RFL-A)
Time Frame: 1 year
The Reasons for Living Inventory for Adolescents (RFL-A; Osman et al, 1998) is a 32-item self-report questionnaire that assesses adaptive reasons that may prevent an adolescent from engaging in life-threatening behavior.
1 year
PHQ-9
Time Frame: 1 year
The current study administered the PHQ-9 to participants 18 years and older. The PHQ-9 (Kroenke et al, 2001) is a widely-used and psychometrically-robust self-report measure used to assess the prevalence of depressive symptoms in adults during a two-week period.
1 year
Columbia-Suicide Severity Rating Scale - Self Report Screener - Recent (C-SSRS).
Time Frame: 1 year
To capture the severity and intensity of participants' SI and their corresponding suicide risk, we used items from the Columbia-Suicide Severity Rating Scale - Screen Version - Recent (C-SSRS; Posner et al, 2011).
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 17, 2014

Primary Completion (Actual)

August 26, 2022

Study Completion (Actual)

August 26, 2022

Study Registration Dates

First Submitted

November 20, 2025

First Submitted That Met QC Criteria

November 20, 2025

First Posted (Actual)

December 1, 2025

Study Record Updates

Last Update Posted (Actual)

December 1, 2025

Last Update Submitted That Met QC Criteria

November 20, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00078098

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidality

Clinical Trials on Enhanced DBT-A

Subscribe